Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMD) Liabilities and Shareholders Equity (2023 - 2025)

Baird Medical Investment Holdings has reported Liabilities and Shareholders Equity over the past 3 years, most recently at $69.7 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 10.6% year-over-year to $69.7 million; the TTM value through Dec 2025 reached $224.7 million, changed N/A, while the annual FY2025 figure was $69.7 million, 10.6% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $69.7 million at Baird Medical Investment Holdings, down from $77.0 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $78.0 million in Q4 2024 and troughed at $56.7 million in Q4 2023.
  • A 3-year average of $70.3 million and a median of $73.3 million in 2025 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: surged 37.48% in 2024 and later decreased 10.6% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $56.7 million in 2023, then soared by 37.48% to $78.0 million in 2024, then fell by 10.6% to $69.7 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for BDMD at $69.7 million in Q4 2025, $77.0 million in Q2 2025, and $78.0 million in Q4 2024.